Michael Kaseta

Director of Finance/CFO at LIQUIDIA CORPORATION

Net worth: 28 M $ as of 29/06/2026

50 year

Health Technology

Consumer Services

Profile

Michael Kaseta currently works at Bryn Pharma LLC, as Director from 2023, Heron Therapeutics, Inc., as Independent Director from 2024, Liquidia Corp., as Chief Financial & Operating Officer from 2024, and Liquidia Technologies, Inc., as Chief Financial & Operating Officer from 2020.
Mr. Kaseta also formerly worked at Alimera Sciences, Inc., as Independent Director from 2023 to 2024, Sanofi, as Chief Financial Officer-Sanofi North America from 2015 to 2016, Aerami Therapeutics, Inc., as Chief Financial Officer from 2019 to 2020, and Old API Wind-down Ltd., as Chief Financial & Accounting Officer from 2018 to 2019.
Mr. Kaseta received his undergraduate degree from James Madison University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LIQUIDIA CORPORATION 0.39%	12/07/2026	345,805 ( 0.39% )	28 M $	29/06/2026
HERON THERAPEUTICS INC 0.02%	13/04/2026	29,787 ( 0.02% )	12 719 $	29/06/2026

Michael Kaseta active positions

Companies	Position	Start
LIQUIDIA CORPORATION	Director of Finance/CFO	29/11/2020
HERON THERAPEUTICS, INC.	Director/Board Member	03/11/2024
Bryn Pharma LLC Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis	Director/Board Member	01/05/2023
Liquidia Technologies, Inc. Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease	Director of Finance/CFO	19/08/2020

All active positions of Michael Kaseta

Former positions of Michael Kaseta

Companies	Position	End
ALIMERA SCIENCES, INC.	Director/Board Member	15/09/2024
Aerami Therapeutics, Inc. Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients	Director of Finance/CFO	31/10/2020
OLD API WIND-DOWN LTD.	Director of Finance/CFO	31/12/2018
SANOFI	Corporate Officer/Principal	31/08/2016

See the detail of Michael Kaseta's experience

Training of Michael Kaseta

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Kaseta's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Heron Therapeutics, Inc. Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Alimera Sciences, Inc. Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems	Health Technology
Liquidia Technologies, Inc. Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease	Health Technology
James Madison University James Madison University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aerami Therapeutics, Inc. Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients	Health Technology
Old API Wind-down Ltd. Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Bryn Pharma LLC Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis	Health Technology
Liquidia Corp. Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology